News

03/14/2022

Thermo Fisher Scientific to add 500 jobs in RVA region

Scientific equipment supplier will invest $97M in three new labs (Virginia Business) Massachusetts-based scientific equipment and software supply company Thermo Fisher Scientific Inc. will invest $97 million to expand its laboratory operations into three new locations in the Greater Richmond area, a project expected to create more than 500 jobs, Gov. Glenn Youngkin announced Monday.

03/10/2022

Virginia Tech and Amazon establish machine learning research partnership

Virginia Tech and Amazon are partnering to advance research and innovation in artificial intelligence and machine learning. The Amazon – Virginia Tech Initiative for Efficient and Robust Machine Learning will include machine learning-focused research projects, doctoral student fellowships, community outreach, and an establishment of a shared advisory board. “This partnership affirms the value of our

03/09/2022

Phlow Launches Key Essential Medicines to Leading Children’s Hospitals to Help Alleviate Impact of Shortages

RICHMOND, Va.–(BUSINESS WIRE)–Phlow, a U.S.-based, public benefit impact-driven pharmaceutical company, announced the launch of key essential medicines, sequentially over the coming quarter, for the Children’s Hospital Coalition™ (CHC), a first-in-kind coalition of leading pediatric institutions. The availability of these medications is an important first step demonstrating Phlow’s commitment to CHC members to provide a reliable

03/03/2022

BIO-CAT Microbials Invests $35 Million in State-of-the-Art Virginia Fermentation Facility

TROY, Va.,  /PRNewswire/ — BIO-CAT Microbials, LLC — a Virginia-based leading microbial solutions company — recently announced a $35 million investment to significantly expand its Troy, Virginia facility to include fermentation capabilities. The company will be breaking ground on an initial 53,800 square-foot expansion phase in March of 2022, with potential future expansion up to an additional 100,000 square feet. The expansion

03/03/2022

Civica to Manufacture and Distribute Affordable Insulin

Americans with diabetes will have access to more affordable insulins through a transparent, cost-plus model Drastically reducing out-of-pocket costs for insulin through transformative collaboration between Civica and dedicated partners representing nearly every corner of the diabetes ecosystem LEHI, Utah –(BUSINESS WIRE)–Civica, Inc. (Civica, Civica Rx) today announced plans to manufacture and distribute insulins that, once

03/02/2022

FDA Approves Kaléo’s 10 mg Naloxone Auto-Injector for the Treatment of Known or Potential Exposure to Ultra-Potent Weaponized Opioids

Product Received Fast-Track Designation for military personnel facing the potential threat of exposure to synthetic opioids on the battlefield on behalf of the U.S. Department of Defense. RICHMOND, Va.–(BUSINESS WIRE)–Kaléo, a privately held U.S. pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved its Naloxone Auto-injector 10 mg (NALOXONE HYDROCHLORIDE